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Abstract
Background: Agitation is common in geriatric patients with cognitive impairment, e.g. in persons with dementia
(PWD), who are admitted to an emergency department (ED). It might be a first sign of upcoming delirium and is
associated with a higher risk of an unfavorable clinical course. Hence, monitoring of vital signs and enhanced
movement as indicators of upcoming agitation is essential in these patients during their stay in the ED. Since PWD
rarely tolerate fixed monitoring devices, a novel developed non-contact monitoring system (NCMSys) might
represent an appropriate alternative.
Aim of this feasibility study was to test the validity of a NCMSys and of the tent-like “Charité Dome” (ChD), aimed to
shelter PWD from the busy ED environment. Furthermore, effects of the ChD on wellbeing and agitation of PWD
were investigated.
Methods: Both devices were attached to patient’s bed. Tests on technical validity and safety issues of NCMSys and
ChD were performed at the iDoc institute with six healthy volunteers. A feasibility study evaluating the reliability of
the NCMSys with and without the ChD was performed in the real-life setting of an ED and on a geriatric-
gerontopsychiatric ward. 19 patients were included, ten males and nine females; mean age: 77.4 (55–93) years of
which 14 were PWD. PWD inclusion criteria were age ≥ 55 years, a dementia diagnosis and a written consent (by
patients or by a custodian). Exclusion criteria were acute life-threatening situations and a missing consent.
Results: Measurements of heart rate, changes in movement and sound emissions by the NCMSys were valid,
whereas patient movements affected respiratory rate measurements. The ChD did not impact patients’ vital signs or
movements in our study setting. However, 53% of the PWD (7/13) and most of the patients without dementia (4/5)
benefited from its use regarding their agitation and overall wellbeing.
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Conclusions: The results of this feasibility study encourage a future controlled clinical trial in geriatric ED patients,
including PWD, to further evaluate if our concept of non-contact measurement of vital signs and movement
combined with the “Charité Dome” helps to prevent upcoming agitation in this vulnerable patient group in the ED.
Trial registration: ICTRP: “Charité-Dome-Study - DRKS00014737” (retrospectively registered).
Keywords: Dementia, agitation, Geriatric care, Non-contact monitoring, Emergency department
Background
Admission to a hospital’s emergency department (ED)
due to an acute medical incident is a threatening situ-
ation for geriatric patients with cognitive impairment,
especially in persons with dementia (PWD) [1]. The
overstimulating surroundings often lead to more agita-
tion and increase the probability of complications such
as the development of delirium, the risk of falls and in-
juries as well as getting lost [2]. Furthermore, older
PWD are more likely to develop a delirium and show a
higher in-hospital mortality compared to older patients
without any cognitive impairment (10.8 vs. 6,6% in a
large retrospective observational study of unscheduled
admissions of patient aged ≥75 years, most of them via
the ED) [3].
PWD’s lack of understanding and therefore missing
cooperation makes their therapy a difficult task to fit in
hospital routine, especially in the ED [2]. Often, the only
possibility to deal with PWD is to administer sedatives
with sometimes hazardous side effects or their fixation
with belts [4]. These conditions result in longer stays,
higher mortality rates and increased functional decline
for PWD in hospital compared to patients without de-
mentia [5, 6]. As a consequence, there is a need for spe-
cial care in terms of ED architecture [7, 8] or devices to
protect PWD from sensory overload and devices to de-
tect and monitor upcoming agitation, possibly indicated
by a change of vital signs, e.g. heart rate and respiratory
rate [9]. As monitoring of vital signs usually requires the
use of adhesive electrodes or the attachment of sensors,
which PWD tend to tear off their body due to discom-
fort [2], the development of new technical tools for non-
contact monitoring of vital signs is necessary. Thus,
wearable devices have been developed [10] that have to
be worn continuously, which is difficult in a hospital
situation with frequent change of gown and the need of
quick access to the patients’ chest in the case of an
emergency. A visible bedside device used e.g. for sleep
apnoea studies [11] might be removed or damaged by
agitated patients.
Many attempts have been made to prevent worsening
of a beginning agitated state in PWD. There is evidence
for preventive efficacy of non-pharmacological treat-
ments [12], though there are no in-hospital studies, es-
pecially in the ED, which mirrors the difficulty to
implement them [13]. Therefore, we developed and
tested a novel non-contact monitoring system (NCMSys)
to monitor vital signs, such as heart and respiratory rate,
combined with monitoring of movement and sound
emissions, without the necessity of a direct patient con-
tact. Furthermore, a tent-like device, the “Charité Dome”
(ChD), was designed, aimed to shelter PWD from sen-
sory overload of the busy ED environment. Both systems
were intertwined from the very beginning of their devel-
opment and were attached to the patient’s bed and eval-
uated in terms of validity of measurements and effects
on patient’s wellbeing and agitation in the real-life set-
ting of an ED and a geriatric-gerontopsychiatric ward.
Here, we present first results of this feasibility study.
Methods
Development of the “Charité dome” (ChD) and the non-
contact monitoring system (NCMSys)
An innovation project of the School of Design Thinking,
Potsdam, Germany, and the Charité Universitätsmedizin
Berlin aimed to improve the complex situation of PWD
in EDs which should be achieved by the development of
a novel system for data collection or analysis and for
shielding of agitated patients. This led to the ChD’s first
prototype. The ChD is a cover for the head section of a
hospital bed, resembling a baby carriage’s convertible
top. It was designed in cooperation with the Gesslein
GmbH, a baby carriage company, the iDoc Institute for
Telemedicine and Health Communication, an expert for
telemedicine, and the department of Human Factors En-
gineering and Ergonomics from the Technical University
of Berlin.
To evaluate the effects of the ChD on upcoming
agitation, mirrored by changes in vital signs, in-
creased movement and sound emissions (e.g. scream-
ing), we developed a NCMSys combining specialized
software and
1) a visual sensor (Mini-Webcam, Conrad Electronics
SE, Hirschau, Germany) detecting changes in
movement (Figure 1a1),
2) an acoustic sensor (ME32, Olympus Imaging
Europa GmbH, Hamburg, Germany) installed to
record potential verbal expression (Figure 1a2),
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3) a sensor mat (SafeBed IP system, Emfit® Ltd.,
Vaajakoski, Finland) with no direct contact to the
test person integrated into the mattress measuring
heart rate, respiratory rate and changes in
movements (Figure 1a3).
All vital signs, movements and sounds were re-
corded simultaneously. The installed video camera
took 24 pictures / second and recorded only differ-
ences of each picture which were expressed as a
signal. Of note, the camera did not record “photo-
graphic images”, only the pixel changes per frame
(24fps) were detected. The same applies for the
recorded audio signals. Only sound intensities in
decibel (dB) and not e.g. spoken words were
detected, recorded and displayed as a graph over
time (Fig. 2a).
Specialized software (iDoc-Studiendatenbank, iDoc-
Institut, Potsdam/Berlin, Germany) collected and visual-
ized the recordings of all connected devices (Fig. 2a).
To evaluate the validity of the NCMSys and safety is-
sues of the ChD, pre-tests with healthy volunteers were
performed, followed by a first feasibility study combining
the ChD and NCMSys in a clinical setting, aiming to test
if there was evidence for a future and well-designed,
controlled clinical trial and thus, depending on the re-
sults, its use in future clinical routine.
Validity of the non-contact monitoring system (NCMSys)
alone and in combination with the “Charité dome” (ChD)
The validity of the presented system was tested at the iDoc
institute. Six healthy volunteers (age 22–82 years) were in-
cluded as test persons. They were connected to a monitor
(model MP5, Philips, Amsterdam, The Netherlands) to
Fig. 1 Arrangement of the non-contact measurement system (NCMSys) and the Charité Dome (ChD). a NCMSys without and b with the ChD
during the feasibility study: (1) visual and (2) acoustic sensor (enlarged illustrated in (c); d sensor mat and (3) its location (4) ECG electrodes; (5)
monitor. e NCMSys and ChD during the feasibility study in the ED
Kroll et al. BMC Psychiatry          (2020) 20:165 Page 3 of 8
measure heart rate and respiratory rate (“standard
monitoring”). Additionally, the new approach of a
combined non-contact monitoring was tested. The
study was conducted in a room equipped with con-
stant lighting conditions and a standard hospital bed
(Fig. 1a) over a period of two hours per test person.
To assess the influence of the ChD on the NCMSys,
the ChD was installed on the bed (Fig. 1b) after the
first hour. Different sorts of sounds were played to
provide a standardized acoustical surrounding and to
test the reliability of the sound recording.
Feasibility study in the ED and a geriatric-
gerontopsychiatric ward
A feasibility study evaluating the effects of the ChD and its
combination with NCMSys was conducted in the ED of
the Charité Universitätsmedizin Berlin at the Campus
Benjamin Franklin and the dementia-specialized geriatric-
Fig. 2 Exemplary screenshots of the simulation software. a Screenshot study non-contact monitoring. (1) number of motions registered by visual
sensor; (2) sound recording; (3) heart rate per minute; (4) respiratory rate per minute; (5) activity registered by sensor mat; (6) timeline. b
Screenshot of the “user-friendly touch-screen interface” for rating (1) emotions: (1a) joy; (1b) anger; (1c) fear; (1d) sadness (only one emotion out
of the four could be selected.); (2) wellbeing/stress; (3) general alertness during the feasibility study in the ED and the
geriatric-gerontopsychiatric ward
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gerontopsychiatric ward of the Oberhavel Kliniken
Hennigsdorf.
Nineteen patients were included, ten males and nine
females. Patients in the ED as well as at the geriatric-
gerontopsychiatric ward were investigated during the
main working hours from Monday to Friday and mainly
in the afternoon, the most busy time in the ED. Eight
patients were included at the ED and eleven patients at
the dementia-specialized geriatric-gerontopsychiatric
ward. They had different acute medical problems. The
mean age of the patients was 77.4 (55 to 93) years. Three
patients of the ED and all eleven patients of the
dementia-specialized geriatric-gerontopsychiatric ward
were PWD. PWD inclusion criteria were age 55 years or
older, a documented dementia diagnosis from the past
medical history (especially patients in the ED) and/or by
Mini Mental Status Examination and assessment by
General Deterioration Scale (patients at the geriatric-
gerontopsychiatric ward) as well as the patients’ or their
legal guardians’ written consent. For patients without de-
mentia, inclusion criteria were age 18 years or older and
the written consent to take part in the study. Exclusion
criteria were acute life-threatening situations (corre-
sponding to Manchester Triage System “red”) or an
acute risk of harm to patients themselves or others and
a missing ability for consent.
In addition, and complementary to the NCMSys an
interface for a standardized assessment of the effects of
the ChD by staff, based on the Observed Emotion Rating
Scale [14] and the Dementia Mood Picture Test [15],
was used during the feasibility study (Fig. 2b). Further-
more, staffs’ comments were registered. In case of con-
flicting results, staffs’ comments were rated higher than
the assessment based on the interface.
The feasibility study in the ED was performed during
daytime and in the more standardized patients’ rooms or
the observation room of the geriatric-gerontopsychiatric
ward. To measure the effects of the ChD on patients’
vital signs, movements and sound emission, monitoring
was performed during two hours per patient. During the
first hour, the patients were lying in a standard hospital
bed equipped with the NCMSys. During the second
hour, the bed was additionally equipped with the ChD
prototype (Fig. 1e).
After each one-hour monitoring with and without
ChD the patients without dementia and – if present –
the relatives of the PWD in the ED were asked to fill out
a standardized form based on the Observed Emotion
Rating Scale regarding the patients’ state of mood.
Patient and public involvement
Patients’ priorities, experience, and preferences did not
affect the development of the research question and out-
come measures. Patients were not involved in the design
of the study nor in the recruitment to and conduct of
the study. Results of the study will be freely available
after their publication.
Statistical analysis
Spearman correlations were performed to analyse differ-
ences between measurements of heart rate and respira-
tory rate by standard monitoring and NCMSys. Effects
of the ChD on heart rate, respiratory rate, the activity
values, and the number of motions were analysed by t
tests. All statistical calculations were performed with the
SPSS Software (Version 23.0).
Results
Validity of non-contact monitoring of heart and
respiratory rate, sound and movement in healthy test
persons
In all six healthy test persons there was a clear correl-
ation for the first (R2 = 0.874; without ChD) and the sec-
ond (R2 = 0.608; with ChD) hour of heart rate
monitoring between the reference monitor and the sen-
sor mat. In contrast, the sensor mat did not show reli-
able measurements of the respiratory rate (correlation of
R2 = 0.840 in the first, R2 = 0.062 in the second hour),
please see Additional file 1. This is a phenomenon also
known from other attempts for a device-assisted monitor-
ing of vital signs [16, 17].
The acoustic sensor showed a valid registration of the
different standardized sounds with only little perturb-
ation and artefacts (Fig. 2a, line 2).
Visual sensor and sensor mat registered changes in
movement. Figure 2a gives a representative example of
the registered changes in movement curves of the visual
sensor (number of motions, line 1) and the sensor mat
(activity, line 5) during a one-hour period with a healthy
test person lying in bed. Depending on the kind of
changes in movement, e.g. just moving hands over or
under the covers, registration by the visual sensor was
not always paralleled by registration of the sensor mat,
pointing to complementarity of both systems. This was
seen even more pronounced when examining patients.
Non-contact monitoring of heart and respiratory rate,
changes of movement and sound emissions in ED
patients and patients on a geriatric-gerontopsychiatric
ward
From 19 patients one patient had to be excluded after
the monitoring started due to missing cooperation,
resulting in 18 patients to be evaluated. Throughout the
test of the ChD, the NCMSys monitored reliably with
only little perturbations and dropouts.
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Effects of the Charité dome measured by the NCMSys and
assessed by staff, patients themselves and relatives
In the specific study setting changes in sound emissions
and heart rate measured by the NCMSys did not show
significant differences between the one hour spent with
and without the ChD (see Additional file 1).
But analysis of the assessment by the attending staff in
the ED and geriatric-gerontopsychiatric ward, patients
themselves and relatives pointed to positive effects on
patients’ mood by assessing emotion, wellbeing, and
alertness (results are summarized in Table 1).
Amelioration was perceived by higher levels of joy,
general alertness and wellbeing. Some patients snuggled
into the panels of the ChD, others were calmer in their
physical agitation. Deterioration was mirrored by de-
creases of mood, alertness and wellbeing. Being re-




We here present a novel concept combining a new non-
contact measurement system of vital parameters and
movement coupled with a tent-like device, aimed to shel-
ter PWD from the busy environment in the ED. The com-
bined system showed valid results in the real-life setting of
an ED and on a geriatric-gerontopsychiatric ward.
Non-contact measurement system (NCMSys)
The NCMSys recording of heart rate, changes in move-
ment and sound emissions were valid in all settings
when test persons or patients were lying in bed.
With regard to extended clinical tests of the NCMSys/
ChD, the obtained correlation values of ~ 0.6–0.8 for
heartrate monitoring between the reference monitor and
the sensor mat needs a further improvement. Neverthe-
less, this is a proof of a new concept. Taking into ac-
count that heart rate measurement in agitated patients
might be even more difficult in terms of accuracy by
established systems which are attached to the patients,
our system works valid in the ED setting.
This was not the case for respiratory rate. The correl-
ation of respiratory rate differed strongly between the
two test hours due to test persons’ and patients’ move-
ments. The latter is a known problem, either when other
systems are used, such as camera photoplethysmography
for heart rate monitoring [16] or sensor mats for con-
tinuous measurements, e.g. in intensive care units, un-
less the patients are asleep or sedated [17]. Thus, we
cannot recommend non-contact measurement of re-
spiratory rate in this setting being in line with other
findings, that to date, non-contact monitoring of respira-
tory rate is not well-engineered for applications in gen-
eral [11]. However, monitoring of respiratory rate is
essential, particularly in the ED. New technical systems
were published just recently [18, 19] but need further
evaluation in the setting “PWD in the ED”.
Changes in vital signs may – to some extent – indicate
upcoming or manifestation of agitation, e.g. in intensive
care patients [9, 20]. Due to the mentioned limitations
of non-contact monitoring of respiratory rate, we there-
fore complemented our system by a visual and an acous-
tic sensor. The tested sensor mat and visual sensor
complemented each other for monitoring changes in
movement: The sensor mat covered pressure-full whole-
body movement like turning, while the visual sensor also
covered smaller movements like fiddling fingers above
the blanket. The latter may mirror increasing nervous-
ness and agitation and was not always detected by the
sensor mats’ monitoring alone or by solely measuring
vital signs. The acoustic sensor should be evaluated in
further studies to complement the system for its use in
the clinical setting.
From the point of practicability, our NCMSys has the
advantage of an easy and quick installation (and de-
installation) on a standard hospital bed, a precondition if
it was used in busy EDs.
“Charité dome” (ChD)
More than half of the PWDs and most of the patients
without dementia lying beneath the ChD experienced
beneficial effects in terms of emotion, wellbeing and
alertness. Thus, the ChD might be suitable counteracting
upcoming agitation. Since “hard-fact” data such as vital
signs are very rare for this patient group, comparable
studies showed, that for measuring the success of non-
pharmaceutical implementations PWD’s experience and
carers’ assessment could be more meaningful than such
data sets [21]. We here confirm this assumption with
our data regarding the ChD, which are mainly based on
the assessment of health care professionals, relatives and
patients themselves.
Table 1 Effects of the Charité Dome on patients’ mood rated
by staff, patients themselves and relatives (summarized).
Assessment is based on the Observed Emotion Rating Scale and
the Dementia Mood Picture Test. Detailed comments of the
staff are shown in Additional file 1
Amelioration No change Deterioration
Emergency Department – Patients without Dementia
4 – 1
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During the two-hour setting of our feasibility study (1 h
without, 1 h with the ChD), no changes of vital signs were
detected by the NCMSys neither in the healthy test per-
sons nor in the patient group. This might be due to the
short time period of measurement and especially due to
the heterogeneity of the studied patients. The patients on
geriatric-gerontopsychiatric ward were mobile, whereas
ED patients were mainly lying in bed because of acute
medical problems. Future studies should focus on the lat-
ter patient group, which then should be monitored by our
system for the whole time of their stay in the ED. How-
ever, for some PWDs the ChD even had an agitation pro-
moting effect. Therefore, a close observation at the
beginning of the lying-beneath-the-ChD-phase in future
studies will be needed to identify those patients.
A major advantage of the ChD compared to e.g. bring-
ing the PWD to a separate room is the limited amount
of space it requires. Especially in the ED the available
space for beds is often limited. Bed curtains also provide
a certain private sphere, though the sheltering effect of
the ChD is much more distinctive. Furthermore, the
ChD mounted to the bed allows to move PWD in the
ED without disturbing there immediate “surrounding”.
However, a respective experimental comparison should
be considered in follow-up studies.
Limitations of the study
Only a few patients were included in our feasibility
study, therefore the population is too small to include a
detailed statistical analysis. Further, the test times were
rather short and were restricted to daytime. The assess-
ments of amelioration and deterioration were estimated
by experienced nursing staff in a non-standardized man-
ner. Therefore, an individual “human factor” cannot be
excluded. Furthermore, even the few patients in the ED
were studied under more “quiet” conditions, although
extrinsic factors causing further stress for patients – be-
side their acute medical problem – could not be ex-
cluded completely. Thus, there might be a bias in the
estimated grade of wellbeing of patients in our setting.
Having in mind a potential translation of our approach
into the clinical routine, more patients and a less artifi-
cial study setting (e.g. a real-life, but defined ED-
surrounding during the whole time of patient’s stay in
the ED) need to be considered in a future controlled
clinical trial.
Conclusions
The combined concept of the presented non-contact
measurement system to detect heart rate, changes in
movement and sound emission complemented by the
ChD might be suitable to detect upcoming agitation, e.g.
due to delirium, and to prevent further deterioration in
older patients with cognitive impairment, including
PWD, bound to bed in the ED. This concept may help
to ameliorate quality of care, e.g. by less demand for sed-
ating medication, and may result in shorter in-hospital
stays of these patients [22]. Furthermore, this may lead
to cost reductions for the public health sector [23] with-
out reduction of quality of care. Future studies will focus
on further technical and design development of the
NCMSys and the ChD, respectively, including a valid
non-contact detection of respiratory rate. The results of
our feasibility study support the initiation of a controlled
clinical trial to evaluate if our system ameliorates level of
care of older patients with cognitive impairment, espe-
cially PWD, in an ED. Such a trial must take the legal
and ethical issues into account, and finally, it must be
emphasized, that a technical solution only can comple-
ment, but never replace personal care of this very vul-
nerable group of patients in the ED.
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Additional file 1: Figure S1. Validity of non-contact monitoring of
heart and respiratory rate, sound, and movement in healthy test-persons.
Linear correlation (A) for the first (correlation of R2 = 0.874) and (B) the
second hour (R2 = 0.608) of HR monitoring between the reference moni-
tor and the SM in all six healthy test persons. Correlation for the measure-
ment of RR (C) in the first (R2 = 0.840) and (D) in the second hour (R2 =
0.062). Figure S2. Effects of the ChD on vital parameters of patients. Vital
parameters of patients lying in bed were measured for one hour without
the ChD followed for one hour with the ChD. Differences for the (A)
heart rate, (B) the respiratory rate, (C) the activity values and (D) the num-
ber of recorded motions were analyzed by multiple t-tests using the
Holm-Sidak method, with alpha = 5.000%. Table S1. Evaluation interface
based on parameters of OERS and DMPT.
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